Previous studies showed that higher CXCL16 expression was associated with M2‐macrophage infiltration and enhanced angiogenesis in thyroid cancer [34], and TAM promoted cancer metastasis by enhancing CXCL16–CXCR6 pathway in ovarian carcinoma [35]. The gene discussed is CXCR6; the disease is thyroid gland carcinoma.